Saturday, February 27, 2016

Novel therapeutic approach to target monomeric Tau protein

Dementia and other tauopathies, most notably Alzheimer’s disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in the human brain. These diseases represent one of the leading causes of death and disability in the elderly population in the western world, with no current effective therapy.

from Dementia Big http://ift.tt/1WPWTGw via alcoholic dementia


http://ift.tt/1S8SOxL

No comments:

Post a Comment